Skip to main content
Skip to main content
CCVAX logo

Calvert Small-Cap Fund Class A (CCVAX) Stock Analysis

$30.21 -$0.31 (-1.02%)
MCap: $1.28B|
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Calvert Small-Cap Fund Class A (CCVAX) trades at $30.21. Calvert Small-Cap Fund Class A (CCVAX) is a mutual fund focused on achieving significant long-term growth by investing primarily in common shares of smaller U. Market cap: $1.28B, Sector: Financial services.

Price as of Aug 21, 2026 · Last analyzed: Jun 15, 2026
Calvert Small-Cap Fund Class A (CCVAX) is a mutual fund focused on achieving significant long-term growth by investing primarily in common shares of smaller U.S. businesses. The fund allocates at least 80% of its net assets to small-company stocks, defined by market valuations comparable to the Russell 2000® Index, with flexibility for up to 25% in non-U.S. securities.

Analyst Coverage for CCVAX: CCVAX does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CCVAX against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.

Watch the CCVAX film Every key number, told as a short cinematic story — just press play. ~2 min
Council Score · Weighted Average of 3 Disciplines
Not yet rated

Not enough scored data yet to form a council read on CCVAX.

How is this calculated? →
Council Score · Weighted Average of 3 Disciplines · See tabs for details →

Calvert Small-Cap Fund Class A (CCVAX) Financial Services Profile

HeadquartersWashington, US
IPO Year2004

Calvert Small-Cap Fund Class A (CCVAX) is an asset management vehicle dedicated to long-term capital appreciation through strategic allocation to U.S. small-capitalization equities. The fund targets companies with market valuations akin to the Russell 2000® Index, maintaining at least 80% exposure to this segment while offering diversification with up to 25% non-U.S. securities.

Data Provenance | Financial Data Quantitative Analysis Analysis: Jun 15, 2026

What Is the Investment Thesis for CCVAX?

As of Jun 15, 2026 — figures reflect the data available on that date.

Calvert Small-Cap Fund Class A (CCVAX) presents an investment vehicle structured for long-term capital appreciation through focused exposure to the U.S. small-capitalization market. With a market capitalization of $1.28B and a Beta of 1.01, the fund's performance is closely aligned with the broader market, particularly the small-cap segment. A primary value driver is its commitment to allocating at least 80% of its net assets to small-company stocks, defined by market valuations comparable to the Russell 2000® Index, offering investors direct access to this growth-oriented sector. The fund's diversification across numerous small-cap holdings is a key strength, aiming to mitigate idiosyncratic risks associated with individual smaller companies. Growth catalysts include potential periods of strong economic expansion that typically benefit small businesses, leading to increased earnings and valuations within the fund's portfolio. The flexibility to invest up to 25% in non-U.S. securities also provides an avenue for additional diversification and potential growth from international small-cap markets. However, investors must consider the inherent volatility of the small-cap market, which can lead to greater price fluctuations compared to large-cap funds. Monitoring the fund's tracking error relative to its benchmark and the overall economic outlook for small businesses remains crucial for assessing its performance.

Based on FMP financials and quantitative analysis

CCVAX Key Highlights

Manages $1.43 billion in assets, indicating significant investor interest and scale within the small-cap fund category.

  • Maintains a Beta of 1.01, suggesting its price movements are closely correlated with the overall market, particularly the small-cap segment.
  • Commits at least 80% of its total net assets to common shares of smaller U.S. businesses, aligning with its core investment mandate.
  • Defines 'small companies' by market valuations comparable to the Russell 2000® Index, providing a clear and consistent investment universe.
  • Offers no dividend yield, reflecting its primary objective of long-term capital appreciation rather than income generation.

Who Are CCVAX's Competitors?

CCVAX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
HQH Abrdn Healthcare Investors $23.84 -3.33% $1.36B 71
ASA ASA Gold and Precious Metals Limited $62.31 +0.10% $1.17B 70
AOD Abrdn Total Dynamic Dividend Fund $10.68 +0.56% $1.13B 68
GSBD Goldman Sachs BDC, Inc. $9.88 +0.82% $1.11B 91
FSCO FS Credit Opportunities Corp. $5.14 -0.58% $1.04B 93
CET Central Securities Corp. $54.21 -0.90% $1.60B 70
MUC BlackRock MuniHoldings California Quality Fund, Inc. $10.60 -0.75% $998M 67
TSLX Sixth Street Specialty Lending, Inc. $18.77 +0.37% $1.78B 68

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are CCVAX's Key Strengths?

Clear investment mandate with at least 80% allocation to U.S. small-cap companies, providing focused exposure.

  • Diversification across numerous small-cap holdings, mitigating individual company risk.
  • Flexibility to invest up to 25% in non-U.S. securities, offering potential for broader growth opportunities and diversification.
  • Aims for long-term capital appreciation, aligning with growth-oriented investor objectives.

What Are CCVAX's Weaknesses?

Inherent volatility of the small-cap market can lead to greater price fluctuations compared to large-cap funds.

  • No dividend yield, which may not appeal to income-focused investors.
  • Potential for tracking error relative to its benchmark index, requiring careful monitoring.
  • Performance is closely tied to the overall small-cap market segment, limiting independent outperformance during broad downturns.

What Could Drive CCVAX Stock Higher?

CCVAX catalyst: Sustained U.S. economic expansion leading to robust earnings growth for small businesses, directly benefiting the fund's underlying holdings.

  • Favorable interest rate environment, such as stable or declining rates, which can reduce borrowing costs for small companies and stimulate investment.
  • Continued investor migration towards diversified small-cap exposure as part of broader portfolio construction strategies, driving inflows into the fund.
  • Strong relative performance against the Russell 2000® Index, attracting new capital and enhancing the fund's market reputation.

What Are the Key Risks for CCVAX?

Inherent volatility of the small-cap market, which can result in significant price fluctuations and potentially higher drawdowns compared to large-cap investments.

  • Economic downturns or recessions, which tend to disproportionately affect smaller businesses due to their more limited resources and market reach.
  • Tracking error relative to the Russell 2000® Index, where the fund's performance may deviate from its stated benchmark due to investment selection or market factors.
  • Regulatory changes within the financial services sector or specific to mutual funds that could increase compliance costs or alter investment flexibility.
  • Increased competition from other small-cap funds, potentially leading to fee pressures or a dilution of market share for Calvert Small-Cap Fund Class A.

What Are the Growth Opportunities for CCVAX?

  • **Favorable Small-Cap Market Performance:** A significant growth opportunity for Calvert Small-Cap Fund Class A lies in periods of robust economic expansion and investor appetite for risk, which typically favor small-capitalization companies. Small-cap stocks often exhibit higher growth rates during economic upturns as they are more sensitive to domestic economic conditions and can expand rapidly from a smaller base. Should the U.S. economy experience sustained growth, leading to increased consumer spending and business investment, the underlying companies within the fund's portfolio could see enhanced revenue and earnings growth. This environment would directly translate into appreciation of the fund's net asset value, attracting new capital and increasing its assets under management. The timeline for such a catalyst is ongoing, dependent on macroeconomic cycles and investor sentiment.
  • **Increased Investor Demand for Diversified Small-Cap Exposure:** As investors increasingly seek diversification beyond large-cap equities and fixed income, the demand for dedicated small-cap exposure could rise. Calvert Small-Cap Fund Class A offers a clear and defined strategy for this segment, providing a convenient vehicle for investors to access a diversified portfolio of smaller companies without the need for individual stock selection. The fund's commitment to at least 80% small-cap allocation, coupled with its flexibility for non-U.S. securities, can appeal to those looking for a balanced approach to small-cap investing. Educational initiatives and market trends highlighting the long-term outperformance potential of small-caps can drive further inflows into funds like CCVAX. This opportunity is ongoing, influenced by market education and evolving investor portfolio strategies.
  • **Strategic Allocation to Non-U.S. Small-Cap Markets:** The fund's flexibility to invest up to 25% of its net assets in non-U.S. securities presents a distinct growth opportunity. This allows the fund to capitalize on growth trends in international small-cap markets that may be outperforming their U.S. counterparts or offer unique diversification benefits. Accessing non-U.S. small-caps can broaden the investment universe, potentially uncovering undervalued companies or those benefiting from specific regional economic tailwinds. This strategic option provides a mechanism for the fund to enhance returns and manage risk by not being solely dependent on the U.S. market. The timeline for this opportunity is ongoing, contingent on global economic conditions and the fund manager's assessment of international market attractiveness.
  • **Potential for Outperformance Against Benchmark:** While the fund's performance is closely tied to the small-cap market, its strategy of 'allocating capital' and 'defining small companies' suggests a managed approach that seeks to identify promising opportunities within the Russell 2000® Index universe. Should the fund's management successfully identify and invest in small-cap companies that outperform the broader index, it could generate alpha and attract more investors seeking superior returns. Consistent outperformance, even modest, can significantly enhance the fund's reputation and appeal, leading to increased asset inflows. This opportunity is ongoing, dependent on the fund's investment selection process and the skill of its management team in navigating the small-cap landscape.
  • **Growing Interest in ESG-Aligned Investing:** Although not explicitly stated in the provided data, Calvert Investments is known for its focus on responsible and sustainable investing. If Calvert Small-Cap Fund Class A integrates environmental, social, and governance (ESG) factors into its investment selection process, it could attract a growing segment of investors prioritizing ESG principles. The market for ESG-aligned funds has been expanding significantly, with investors increasingly looking for investment vehicles that align with their values. Positioning the fund as a small-cap option with a responsible investing overlay could differentiate it in a crowded market and tap into this expanding investor base. This is a potential future opportunity, contingent on the fund's explicit ESG integration and market communication.

What Threats Does CCVAX Face?

  • Economic downturns or recessions can disproportionately impact small businesses, leading to underperformance.
  • Increased competition from other small-cap mutual funds and ETFs, potentially pressuring fees and market share.
  • Adverse regulatory changes impacting mutual funds or the broader financial services industry.
  • Sustained periods of underperformance relative to its benchmark or peer group could lead to investor outflows.

What Are CCVAX's Competitive Advantages?

  • **Diversification:** Offers a diversified portfolio of small-cap companies, reducing single-stock risk for investors.
  • **Defined Investment Mandate:** A clear strategy of investing at least 80% in small U.S. companies, benchmarked to the Russell 2000® Index, provides transparency and focus.
  • **Brand Reputation:** As part of Calvert, a known entity in asset management, the fund benefits from established trust and investor recognition.
  • **Access to Expertise:** Leverages the investment research and management capabilities of its parent organization to identify and select small-cap opportunities.

What Does CCVAX Do?

The Calvert Small-Cap Fund Class A (CCVAX) operates within the asset management industry, specifically targeting the small-capitalization segment of the equity market. Its core objective is to deliver significant long-term growth for investors by strategically allocating capital to the common shares of smaller U.S. businesses. The fund's investment strategy is clearly defined: at least 80% of its total net assets, which includes any borrowed capital utilized for investment purposes, are dedicated to these small-company stocks. This commitment ensures a focused exposure to the growth potential inherent in smaller enterprises. The fund's management employs a specific criterion for defining "small companies," considering those with market valuations comparable to the constituents of the Russell 2000® Index at the time of investment. This benchmark provides a consistent framework for identifying suitable investment opportunities within the small-cap universe. While primarily focused on domestic small-caps, the fund maintains a degree of flexibility, allowing it to invest up to a maximum of 25% of its net assets in non-U.S. securities. This provision enables the fund to potentially capture growth opportunities outside the U.S. market or enhance diversification, depending on market conditions and the fund manager's assessment. As a mutual fund, CCVAX provides investors with a diversified portfolio of small-cap holdings, aiming to mitigate individual stock risk while participating in the broader small-cap market's performance. The fund's approach combines a clear mandate for long-term growth with a defined investment universe, positioning it as a vehicle for investors seeking exposure to this dynamic market segment.

What Products and Services Does CCVAX Offer?

  • Invests primarily in common shares of smaller U.S. businesses.
  • Seeks to deliver significant long-term growth for investors.
  • Allocates at least 80% of its total net assets to small-company stocks.
  • Defines 'small companies' as those with market valuations comparable to the Russell 2000® Index at the time of investment.
  • Has the flexibility to invest up to 25% of its net assets in non-U.S. securities.
  • Provides investors with diversified exposure to the small-capitalization equity market.
  • Operates as a mutual fund, pooling investor capital for collective investment.

How Does CCVAX Make Money?

  • Generates revenue through management fees charged as a percentage of assets under management (AUM).
  • Incurs operating expenses, including administrative, marketing, and distribution costs, which are typically passed on to investors through an expense ratio.
  • Aims to increase its net asset value (NAV) per share through capital appreciation of its underlying investments.
  • Attracts and retains investor capital by delivering competitive long-term returns relative to its investment objective and benchmark.

What Industry Does CCVAX Operate In?

Calvert Small-Cap Fund Class A operates within the highly competitive asset management industry, specifically targeting the small-capitalization equity segment. This industry is characterized by a diverse range of investment products, including mutual funds, exchange-traded funds (ETFs), and separately managed accounts, all vying for investor capital. The small-cap market segment itself is known for its higher growth potential and increased volatility compared to large-cap markets, often attracting investors seeking aggressive growth opportunities. CCVAX positions itself as a dedicated vehicle for accessing this segment, with its strategy of investing at least 80% of its net assets in small U.S. companies. The competitive landscape includes numerous other small-cap funds offered by major financial institutions, each with varying investment philosophies, expense ratios, and management styles. CCVAX's adherence to the Russell 2000® Index as a benchmark for defining small companies places it directly in competition with funds that track or aim to outperform this widely recognized small-cap index, necessitating consistent performance and clear communication of its investment approach to attract and retain investors.

Who Are CCVAX's Key Customers?

  • Individual investors seeking long-term capital growth.
  • Financial advisors and wealth managers allocating client portfolios.
  • Institutional investors looking for diversified small-cap equity exposure.
  • Investors comfortable with the higher volatility associated with small-capitalization stocks.
AI Confidence: 78% Updated: Jun 15, 2026

CCVAX Financials

Bull Case vs Bear Case

Bull Case

  • Clear investment mandate with at least 80% allocation to U.S. small-cap companies, providing focused exposure.
  • Diversification across numerous small-cap holdings, mitigating individual company risk.
  • Flexibility to invest up to 25% in non-U.S. securities, offering potential for broader growth opportunities and diversification.
  • Aims for long-term capital appreciation, aligning with growth-oriented investor objectives.

Bear Case

  • Inherent volatility of the small-cap market can lead to greater price fluctuations compared to large-cap funds.
  • No dividend yield, which may not appeal to income-focused investors.
  • Potential for tracking error relative to its benchmark index, requiring careful monitoring.
  • Performance is closely tied to the overall small-cap market segment, limiting independent outperformance during broad downturns.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026

CCVAX Latest News

No recent news available for CCVAX.

CCVAX Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CCVAX.

Price Targets

Wall Street price target analysis for CCVAX.

CCVAX MoonshotScore

0/100

What does this score mean?

The MoonshotScore rates CCVAX 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.

Calvert Small-Cap Fund Class A Financial Services Stock: Key Questions Answered

What is the investment objective of Calvert Small-Cap Fund Class A?

The primary investment objective of Calvert Small-Cap Fund Class A (CCVAX) is to deliver significant long-term growth for its investors. The fund aims to achieve this by primarily investing in the common shares of smaller U.S. businesses.

How does Calvert Small-Cap Fund Class A define 'small companies' for its investments?

Calvert Small-Cap Fund Class A employs a specific and consistent definition for the "small companies" it targets for investment. According to its strategy, small companies are identified as those with market valuations that are comparable to the companies comprising the Russell 2000® Index.

What are the primary risks associated with investing in Calvert Small-Cap Fund Class A?

Investing in Calvert Small-Cap Fund Class A carries several primary risks inherent to its investment strategy and the small-cap market. The most significant risk is the inherent volatility of the small-capitalization market, which typically experiences greater price fluctuations compared to large-cap segments. This can lead to more pronounced gains but also more substantial losses.

How does Calvert Small-Cap Fund Class A generate returns for its investors?

Calvert Small-Cap Fund Class A primarily generates returns for its investors through capital appreciation of its underlying equity holdings. As a mutual fund, it invests in a diversified portfolio of common shares of smaller U.S. businesses. When the market value of these companies increases, the net asset value (NAV) per share of the fund rises, leading to gains for investors.

What is the role of the Russell 2000® Index in Calvert Small-Cap Fund Class A's strategy?

The Russell 2000® Index plays a crucial role in Calvert Small-Cap Fund Class A's investment strategy by serving as the benchmark for defining "small companies." The fund's management identifies small companies as those with market valuations comparable to the constituents of the Russell 2000® Index at the time of investment.

What are the key factors to evaluate for CCVAX?

Evaluate CCVAX on fundamentals, analyst consensus, and risk factors. Calvert Small-Cap Fund Class A (CCVAX) presents an investment vehicle structured for long-term capital appreciation through focused exposure to the U.S. Not financial advice.

How frequently does CCVAX data refresh on this page?

CCVAX's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven CCVAX's recent stock price performance?

Calvert Small-Cap Fund Class A (CCVAX) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Clear investment mandate with at least 80% allocation to U.S. small-cap companies, providing focused exposure. See the News tab for the latest drivers. Past performance does not predict future results.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • The business model for mutual funds (e.g., management fees, expense ratios) is inferred based on standard industry practices, as specific fee structures were not provided in the source data.
  • The AI insight's statement 'As a passively managed fund' was reconciled with the business description's 'primary strategy involves allocating capital' by focusing on the fund's defined strategy and market exposure rather than explicitly labeling it as purely 'passive' or 'active' given the potential contradiction.
  • Growth opportunity related to ESG was added based on general knowledge of Calvert's brand, but it's noted as a 'potential future opportunity' as specific ESG integration for this fund was not in the provided text.
Data Sources

Popular Stocks

More Stocks We Cover